Evidence map›Paper›PMID 41579517›Full record

ArticleInternational journal of gynecological cancer : official journal of the International Gynecological Cancer Society2026

The International Gynecologic Cancer Society Global Fellowship Program: advancing access to gynecologic oncology and surgical care worldwide.

Parisa N Fallah, Anisa Mburu, Ricardina Rangeiro, Saujanya Karmacharya, Mukatimui Kalima-Munalula, Erick E Estrada, Martin Origa, Husnia Hussen Lobi, Henry Chege, Deazee M Saywon and 12 more

Abstract read
In one paragraph

Article in International journal of gynecological cancer : official journal of the International Gynecological Cancer Society, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Parisa N FallahThe University of Texas MD Anderson Cancer Center, Department of Gynecologic Oncology and Reproductive Medicine, Houston, TX, USA.
Anisa MburuAga Khan Hospital, Department of Gynecologic Oncology, Mombasa, Kenya.
Ricardina RangeiroHospital Central de Maputo, Department of Gynecologic Oncology, Maputo, Mozambique.
Saujanya KarmacharyaNepal Armed Police Force Hospital, Department of Gynecologic Oncology, Chandragiri, Nepal.
Mukatimui Kalima-MunalulaWomen and Newborn Hospital, Department of Gynecologic Oncology, Lusaka, Zambia.
Erick E EstradaHospital General San Juan de Dios, Department of Gynecologic Oncology, Guatemala City, Guatemala.
Martin OrigaUganda Cancer Institute, Department of Gynecologic Oncology, Kampala, Uganda.
Husnia Hussen LobiAddis Ababa University, Black Lion Hospital, Department of Gynecologic Oncology, Addis, Ababa, Ethiopia.
Henry ChegeNyeri County Referral Hospital, Department of Gynecologic Oncology, Nyeri, Kenya.
Deazee M SaywonJohn F. Kennedy Memorial Hospital, Department of Gynecologic Oncology, Monrovia, Liberia.
Saida BoweRand Memorial Hospital, Department of Gynecologic Oncology, Freeport, Bahamas.
Ngoc PhanDanang Oncology Hospital, Department of Gynecologic Oncology, Danang, Vietnam.
Joy MuhumuzaMbarara University of Science and Technology, Department of Gynecologic Oncology, Mbarara, Uganda.
Susan RalphInternational Gynecologic Cancer Society, Chicago, IL, USA.
Mary EikenInternational Gynecologic Cancer Society, Chicago, IL, USA.
Edward TrimbleNational Institutes of Health, National Cancer Institute, Bethesda, MD, USA; National Institutes of Health, National Cancer Institute, Bethesda, MD, USA.
Michael QuinnRoyal Women's Hospital, Department of Gynecologic Oncology, Melbourne, Australia; Royal Women's Hospital, Department of Gynecologic Oncology, Melbourne, Australia.
Allan CovensSunnybrook Health Sciences Center, Department of Gynecologic Oncology, University of Toronto, Toronto, Canada.
Linus T ChuangInternational Gynecologic Cancer Society, Chicago, IL, USA; Danbury Hospital - Nuvance Health, Department of Gynecologic Oncology, Danbury, CT, USA.
Joseph S NgInternational Gynecologic Cancer Society, Chicago, IL, USA; National University Hospital, Department of Gynecologic Oncology, Singapore City, Singapore.
Thomas C RandallInternational Gynecologic Cancer Society, Chicago, IL, USA; Columbia University Irving Medical Center, Department of Gynecologic Oncology, New York City, NY, USA.
Kathleen M SchmelerThe University of Texas MD Anderson Cancer Center, Department of Gynecologic Oncology and Reproductive Medicine, Houston, TX, USA; International Gynecologic Cancer Society, Chicago, IL, USA. Electronic address: kschmele@mdanderson.org.

Funding

Tumor Evolution and Metastasis ProgramP30CA016672 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI Fabien Delerue · 1985 to 2026
$290.8M
Training of Academic Gynecologic OncologistsT32CA101642 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI ANIL K SOOD, Kathleen Schmeler · 2005 to 2026
$9.2M
NCI NIH HHS P30 CA016672NCI NIH HHS T32 CA101642
6 · The paper itself

Abstract

objectiveGynecologic malignancies remain a leading cause of death among women in low- and middle-income countries. In 2017, the International Gynecologic Cancer Society (IGCS) started the Global Gynecologic Oncology Fellowship Program in countries without existing training. This 2-year structured program allows fellows to train locally with support from international mentors through in-person visits, virtual mentorship, and didactic instruction. Fellows participate in monthly tumor boards, conduct research, complete international observerships, log surgical cases, and complete an oral exam upon graduation. Our objective was to characterize the growth of this program from 2017 to 2024 and determine best practices and areas for improvement.

methodsBetween February and April 2024, 40 IGCS fellowship graduates were invited via email to complete a 38-question survey about their training and post-fellowship experiences. Data were analyzed using descriptive statistics and thematic analysis.

resultsSince 2017, the IGCS fellowship program has expanded from 5 pilot sites to 22 training sites in 18 countries. To date, 52 fellows have graduated and 38 are currently in training. There are 40 international mentors and 53 local supervisors, of whom 15 are previous graduates. Twenty fellows (50%) completed the survey. Nineteen respondents (95.0%) reported practicing as gynecologic oncologists, with an average of 70% of their clinical work focused on this area. However, most reported continuing to provide obstetric and benign gynecology care. Six respondents (30%) reported being the sole gynecologic oncologist at their hospital. Half of respondents never visited their international mentor's site, although 70% reported consistent virtual support. All graduates expressed a need for post-fellowship support, including mentorship, meetings with other graduates, advanced surgical training, and sub-specialty collaboration.

conclusionsThe IGCS fellowship program has significantly expanded gynecologic oncology capacity in low-resource settings. Graduates report valuable training experiences but desire ongoing post-fellowship support, a next step in growth for the IGCS fellowship program.

Indexed as

Fellowships and ScholarshipsGenital Neoplasms, FemaleGynecologic Surgical ProceduresGynecologyMedical OncologyFemaleGlobal HealthHealth Services AccessibilityHumansSocieties, MedicalSurveys and QuestionnairesCapacity-BuildingGlobal HealthGynecologic OncologySurgery

Identifiers

PMID41579517
PMCPMC12912822

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.